Nanovibronix (NAOV) Competitors $0.92 -0.01 (-0.54%) As of 10:14 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NAOV vs. LYRA, DHAI, IINN, INBS, WOK, PAVM, BTCY, SSKN, NURO, and CODXShould you be buying Nanovibronix stock or one of its competitors? The main competitors of Nanovibronix include Lyra Therapeutics (LYRA), DIH Holding US (DHAI), Inspira Technologies OXY B.H.N. (IINN), Intelligent Bio Solutions (INBS), WORK Medical Technology Group (WOK), PAVmed (PAVM), Biotricity (BTCY), Strata Skin Sciences (SSKN), NeuroMetrix (NURO), and Co-Diagnostics (CODX). These companies are all part of the "medical equipment" industry. Nanovibronix vs. Its Competitors Lyra Therapeutics DIH Holding US Inspira Technologies OXY B.H.N. Intelligent Bio Solutions WORK Medical Technology Group PAVmed Biotricity Strata Skin Sciences NeuroMetrix Co-Diagnostics Lyra Therapeutics (NASDAQ:LYRA) and Nanovibronix (NASDAQ:NAOV) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, media sentiment, dividends, earnings, risk, analyst recommendations, profitability and valuation. Which has stronger earnings and valuation, LYRA or NAOV? Nanovibronix has higher revenue and earnings than Lyra Therapeutics. Lyra Therapeutics is trading at a lower price-to-earnings ratio than Nanovibronix, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLyra Therapeutics$1.53M7.82-$93.43M-$60.50-0.15Nanovibronix$2.56M0.93-$3.70M-$13.53-0.07 Does the media favor LYRA or NAOV? In the previous week, Lyra Therapeutics had 1 more articles in the media than Nanovibronix. MarketBeat recorded 1 mentions for Lyra Therapeutics and 0 mentions for Nanovibronix. Lyra Therapeutics' average media sentiment score of 0.49 beat Nanovibronix's score of 0.00 indicating that Lyra Therapeutics is being referred to more favorably in the media. Company Overall Sentiment Lyra Therapeutics Neutral Nanovibronix Neutral Is LYRA or NAOV more profitable? Nanovibronix has a net margin of -210.82% compared to Lyra Therapeutics' net margin of -6,711.39%. Nanovibronix's return on equity of -54.73% beat Lyra Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Lyra Therapeutics-6,711.39% -295.52% -66.95% Nanovibronix -210.82%-54.73%-38.63% Do analysts rate LYRA or NAOV? Lyra Therapeutics presently has a consensus target price of $100.00, indicating a potential upside of 1,011.73%. Given Lyra Therapeutics' stronger consensus rating and higher probable upside, equities analysts plainly believe Lyra Therapeutics is more favorable than Nanovibronix.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lyra Therapeutics 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33Nanovibronix 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do institutionals and insiders have more ownership in LYRA or NAOV? 95.6% of Lyra Therapeutics shares are held by institutional investors. Comparatively, 16.4% of Nanovibronix shares are held by institutional investors. 3.3% of Lyra Therapeutics shares are held by company insiders. Comparatively, 6.3% of Nanovibronix shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Which has more risk & volatility, LYRA or NAOV? Lyra Therapeutics has a beta of 0.24, suggesting that its share price is 76% less volatile than the S&P 500. Comparatively, Nanovibronix has a beta of 1.71, suggesting that its share price is 71% more volatile than the S&P 500. SummaryNanovibronix beats Lyra Therapeutics on 9 of the 16 factors compared between the two stocks. Get Nanovibronix News Delivered to You Automatically Sign up to receive the latest news and ratings for NAOV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NAOV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NAOV vs. The Competition Export to ExcelMetricNanovibronixMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.39M$6.81B$5.50B$8.99BDividend YieldN/A1.14%5.22%3.99%P/E Ratio-0.0726.3327.6320.18Price / Sales0.93110.39432.00117.08Price / CashN/A21.4826.2128.59Price / Book0.504.777.945.71Net Income-$3.70M$173.18M$3.18B$248.99M7 Day Performance-0.24%33.19%5.09%8.00%1 Month Performance2.78%15.34%3.10%8.88%1 Year Performance-88.32%29.84%35.48%21.87% Nanovibronix Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NAOVNanovibronix0.0757 of 5 stars$0.93-0.5%N/A-88.2%$2.39M$2.56M-0.0720LYRALyra Therapeutics2.0445 of 5 stars$8.96-1.6%$100.00+1,016.1%-33.7%$12.07M$1.53M-0.1550Analyst UpgradeDHAIDIH Holding US0.6701 of 5 stars$0.24-2.4%N/A-92.1%$11.88M$64.47M-0.82N/AGap DownIINNInspira Technologies OXY B.H.N.2.8543 of 5 stars$0.85flat$2.00+135.3%-13.6%$10.73MN/A0.0020INBSIntelligent Bio Solutions0.1244 of 5 stars$1.72+12.4%N/A+1.6%$10.57M$3.11M0.0010WOKWORK Medical Technology GroupN/A$0.69-3.5%N/AN/A$10.43M$11.51M0.00226Gap UpPAVMPAVmed3.951 of 5 stars$0.60+0.1%$19.00+3,065.1%-15.7%$10.26M$2.99M0.8590BTCYBiotricityN/A$0.37-7.9%N/A-45.1%$10.02M$12.06M-0.3440Gap DownSSKNStrata Skin Sciences2.8472 of 5 stars$2.29+1.8%$6.00+162.0%-23.0%$9.39M$33.56M-1.01120Gap DownNURONeuroMetrixN/A$4.55+4.4%N/A+23.0%$9.37M$3.03M-0.9920High Trading VolumeCODXCo-Diagnostics3.699 of 5 stars$0.28+6.7%$5.50+1,862.9%-77.0%$8.81M$3.91M-0.24100Gap Up Related Companies and Tools Related Companies Lyra Therapeutics Competitors DIH Holding US Competitors Inspira Technologies OXY B.H.N. Competitors Intelligent Bio Solutions Competitors WORK Medical Technology Group Competitors PAVmed Competitors Biotricity Competitors Strata Skin Sciences Competitors NeuroMetrix Competitors Co-Diagnostics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NAOV) was last updated on 7/7/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nanovibronix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nanovibronix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
